Safety and Immunogenicity of the Merck Adenovirus Serotype 5 (MRKAd5) and MRKAd6 Human Immunodeficiency Virus Type 1 Trigene Vaccines Alone and in Combination in Healthy Adults
Author(s) -
Clayton Harro,
Xiao Sun,
Jon E. Stek,
Randi Y. Leavitt,
Devan V. Mehrotra,
Fubao Wang,
Andrew J. Bett,
Danilo R. Casimiro,
John W. Shiver,
Mark J. DiNubile,
Erin Quirk
Publication year - 2009
Publication title -
clinical and vaccine immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.649
H-Index - 77
eISSN - 1556-6811
pISSN - 1556-679X
DOI - 10.1128/cvi.00473-09
Subject(s) - immunogenicity , virology , serotype , human immunodeficiency virus (hiv) , medicine , immunology , biology , antibody
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom